TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Pet Anthelmintic Drugs Market Insights, Forecast to 2028

Global Pet Anthelmintic Drugs Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 09 June 2022
  • Pages :114
  • Formats:
  • Report Code:SMR-7143329
OfferClick for best price

Best Price: $3920

Pet Anthelmintic Drugs Market Size, Share 2022


Market Analysis and Insights: Global Pet Anthelmintic Drugs Market

The global Pet Anthelmintic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pet Anthelmintic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pet Anthelmintic Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pet Anthelmintic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pet Anthelmintic Drugs market.

Global Pet Anthelmintic Drugs Scope and Market Size

Pet Anthelmintic Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pet Anthelmintic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

External

Internal

Composite

Injection

Segment by Application

Dog

Cat

Others

By Company

Elanco

Boehringer Ingelheim

Ceva Sante Animale

Chanelle Group

Dechra

Durvet

First Priority

Jeffers

Manna Pro Products

Merck Animal Health

Ourofino

TTK Healthcare

Vetoquinol

Virbac

Zoetis

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Pet Anthelmintic Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Pet Anthelmintic Drugs, with price, sales, revenue, and global market share of Pet Anthelmintic Drugs from 2019 to 2022.

Chapter 3, the Pet Anthelmintic Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pet Anthelmintic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Pet Anthelmintic Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Pet Anthelmintic Drugs.

Chapter 13, 14, and 15, to describe Pet Anthelmintic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Pet Anthelmintic Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Pet Anthelmintic Drugs Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 114 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 External
1.2.3 Internal
1.2.4 Composite
1.2.5 Injection
1.3 Market by Application
1.3.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pet Anthelmintic Drugs Market Perspective (2017-2028)
2.2 Pet Anthelmintic Drugs Growth Trends by Region
2.2.1 Pet Anthelmintic Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pet Anthelmintic Drugs Historic Market Size by Region (2017-2022)
2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Region (2023-2028)
2.3 Pet Anthelmintic Drugs Market Dynamics
2.3.1 Pet Anthelmintic Drugs Industry Trends
2.3.2 Pet Anthelmintic Drugs Market Drivers
2.3.3 Pet Anthelmintic Drugs Market Challenges
2.3.4 Pet Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2017-2022)
3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2021
3.5 Pet Anthelmintic Drugs Key Players Head office and Area Served
3.6 Key Players Pet Anthelmintic Drugs Product Solution and Service
3.7 Date of Enter into Pet Anthelmintic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Anthelmintic Drugs Breakdown Data by Type
4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2017-2022)
4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2023-2028)
5 Pet Anthelmintic Drugs Breakdown Data by Application
5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2017-2022)
5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pet Anthelmintic Drugs Market Size (2017-2028)
6.2 North America Pet Anthelmintic Drugs Market Size by Type
6.2.1 North America Pet Anthelmintic Drugs Market Size by Type (2017-2022)
6.2.2 North America Pet Anthelmintic Drugs Market Size by Type (2023-2028)
6.2.3 North America Pet Anthelmintic Drugs Market Share by Type (2017-2028)
6.3 North America Pet Anthelmintic Drugs Market Size by Application
6.3.1 North America Pet Anthelmintic Drugs Market Size by Application (2017-2022)
6.3.2 North America Pet Anthelmintic Drugs Market Size by Application (2023-2028)
6.3.3 North America Pet Anthelmintic Drugs Market Share by Application (2017-2028)
6.4 North America Pet Anthelmintic Drugs Market Size by Country
6.4.1 North America Pet Anthelmintic Drugs Market Size by Country (2017-2022)
6.4.2 North America Pet Anthelmintic Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pet Anthelmintic Drugs Market Size (2017-2028)
7.2 Europe Pet Anthelmintic Drugs Market Size by Type
7.2.1 Europe Pet Anthelmintic Drugs Market Size by Type (2017-2022)
7.2.2 Europe Pet Anthelmintic Drugs Market Size by Type (2023-2028)
7.2.3 Europe Pet Anthelmintic Drugs Market Share by Type (2017-2028)
7.3 Europe Pet Anthelmintic Drugs Market Size by Application
7.3.1 Europe Pet Anthelmintic Drugs Market Size by Application (2017-2022)
7.3.2 Europe Pet Anthelmintic Drugs Market Size by Application (2023-2028)
7.3.3 Europe Pet Anthelmintic Drugs Market Share by Application (2017-2028)
7.4 Europe Pet Anthelmintic Drugs Market Size by Country
7.4.1 Europe Pet Anthelmintic Drugs Market Size by Country (2017-2022)
7.4.2 Europe Pet Anthelmintic Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2017-2028)
8.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type
8.2.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pet Anthelmintic Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application
8.3.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pet Anthelmintic Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region
8.4.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pet Anthelmintic Drugs Market Size (2017-2028)
9.2 Latin America Pet Anthelmintic Drugs Market Size by Type
9.2.1 Latin America Pet Anthelmintic Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Pet Anthelmintic Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Pet Anthelmintic Drugs Market Share by Type (2017-2028)
9.3 Latin America Pet Anthelmintic Drugs Market Size by Application
9.3.1 Latin America Pet Anthelmintic Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Pet Anthelmintic Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Pet Anthelmintic Drugs Market Share by Application (2017-2028)
9.4 Latin America Pet Anthelmintic Drugs Market Size by Country
9.4.1 Latin America Pet Anthelmintic Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Pet Anthelmintic Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2017-2028)
10.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type
10.2.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pet Anthelmintic Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application
10.3.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pet Anthelmintic Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country
10.4.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Elanco Business Overview
11.1.3 Elanco Pet Anthelmintic Drugs Introduction
11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.1.5 Elanco Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.3.5 Ceva Sante Animale Recent Developments
11.4 Chanelle Group
11.4.1 Chanelle Group Company Details
11.4.2 Chanelle Group Business Overview
11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.4.5 Chanelle Group Recent Developments
11.5 Dechra
11.5.1 Dechra Company Details
11.5.2 Dechra Business Overview
11.5.3 Dechra Pet Anthelmintic Drugs Introduction
11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.5.5 Dechra Recent Developments
11.6 Durvet
11.6.1 Durvet Company Details
11.6.2 Durvet Business Overview
11.6.3 Durvet Pet Anthelmintic Drugs Introduction
11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.6.5 Durvet Recent Developments
11.7 First Priority
11.7.1 First Priority Company Details
11.7.2 First Priority Business Overview
11.7.3 First Priority Pet Anthelmintic Drugs Introduction
11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.7.5 First Priority Recent Developments
11.8 Jeffers
11.8.1 Jeffers Company Details
11.8.2 Jeffers Business Overview
11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.8.5 Jeffers Recent Developments
11.9 Manna Pro Products
11.9.1 Manna Pro Products Company Details
11.9.2 Manna Pro Products Business Overview
11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.9.5 Manna Pro Products Recent Developments
11.10 Merck Animal Health
11.10.1 Merck Animal Health Company Details
11.10.2 Merck Animal Health Business Overview
11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.10.5 Merck Animal Health Recent Developments
11.11 Ourofino
11.11.1 Ourofino Company Details
11.11.2 Ourofino Business Overview
11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.11.5 Ourofino Recent Developments
11.12 TTK Healthcare
11.12.1 TTK Healthcare Company Details
11.12.2 TTK Healthcare Business Overview
11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.12.5 TTK Healthcare Recent Developments
11.13 Vetoquinol
11.13.1 Vetoquinol Company Details
11.13.2 Vetoquinol Business Overview
11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.13.5 Vetoquinol Recent Developments
11.14 Virbac
11.14.1 Virbac Company Details
11.14.2 Virbac Business Overview
11.14.3 Virbac Pet Anthelmintic Drugs Introduction
11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.14.5 Virbac Recent Developments
11.15 Zoetis
11.15.1 Zoetis Company Details
11.15.2 Zoetis Business Overview
11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2017-2022)
11.15.5 Zoetis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of External
Table 3. Key Players of Internal
Table 4. Key Players of Composite
Table 5. Key Players of Injection
Table 6. Global Pet Anthelmintic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Pet Anthelmintic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Pet Anthelmintic Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Pet Anthelmintic Drugs Market Share by Region (2017-2022)
Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Pet Anthelmintic Drugs Market Share by Region (2023-2028)
Table 12. Pet Anthelmintic Drugs Market Trends
Table 13. Pet Anthelmintic Drugs Market Drivers
Table 14. Pet Anthelmintic Drugs Market Challenges
Table 15. Pet Anthelmintic Drugs Market Restraints
Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Pet Anthelmintic Drugs Revenue Share by Players (2017-2022)
Table 18. Global Top Pet Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2021)
Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pet Anthelmintic Drugs Product Solution and Service
Table 23. Date of Enter into Pet Anthelmintic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Pet Anthelmintic Drugs Revenue Share by Application (2017-2022)
Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Pet Anthelmintic Drugs Revenue Share by Application (2023-2028)
Table 33. North America Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Pet Anthelmintic Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Pet Anthelmintic Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 63. Elanco Company Details
Table 64. Elanco Business Overview
Table 65. Elanco Pet Anthelmintic Drugs Product
Table 66. Elanco Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 67. Elanco Recent Developments
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Pet Anthelmintic Drugs Product
Table 71. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Developments
Table 73. Ceva Sante Animale Company Details
Table 74. Ceva Sante Animale Business Overview
Table 75. Ceva Sante Animale Pet Anthelmintic Drugs Product
Table 76. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 77. Ceva Sante Animale Recent Developments
Table 78. Chanelle Group Company Details
Table 79. Chanelle Group Business Overview
Table 80. Chanelle Group Pet Anthelmintic Drugs Product
Table 81. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 82. Chanelle Group Recent Developments
Table 83. Dechra Company Details
Table 84. Dechra Business Overview
Table 85. Dechra Pet Anthelmintic Drugs Product
Table 86. Dechra Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 87. Dechra Recent Developments
Table 88. Durvet Company Details
Table 89. Durvet Business Overview
Table 90. Durvet Pet Anthelmintic Drugs Product
Table 91. Durvet Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 92. Durvet Recent Developments
Table 93. First Priority Company Details
Table 94. First Priority Business Overview
Table 95. First Priority Pet Anthelmintic Drugs Product
Table 96. First Priority Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 97. First Priority Recent Developments
Table 98. Jeffers Company Details
Table 99. Jeffers Business Overview
Table 100. Jeffers Pet Anthelmintic Drugs Product
Table 101. Jeffers Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 102. Jeffers Recent Developments
Table 103. Manna Pro Products Company Details
Table 104. Manna Pro Products Business Overview
Table 105. Manna Pro Products Pet Anthelmintic Drugs Product
Table 106. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 107. Manna Pro Products Recent Developments
Table 108. Merck Animal Health Company Details
Table 109. Merck Animal Health Business Overview
Table 110. Merck Animal Health Pet Anthelmintic Drugs Product
Table 111. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 112. Merck Animal Health Recent Developments
Table 113. Ourofino Company Details
Table 114. Ourofino Business Overview
Table 115. Ourofino Pet Anthelmintic Drugs Product
Table 116. Ourofino Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 117. Ourofino Recent Developments
Table 118. TTK Healthcare Company Details
Table 119. TTK Healthcare Business Overview
Table 120. TTK Healthcare Pet Anthelmintic Drugs Product
Table 121. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 122. TTK Healthcare Recent Developments
Table 123. Vetoquinol Company Details
Table 124. Vetoquinol Business Overview
Table 125. Vetoquinol Pet Anthelmintic Drugs Product
Table 126. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 127. Vetoquinol Recent Developments
Table 128. Virbac Company Details
Table 129. Virbac Business Overview
Table 130. Virbac Pet Anthelmintic Drugs Product
Table 131. Virbac Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 132. Virbac Recent Developments
Table 133. Zoetis Company Details
Table 134. Zoetis Business Overview
Table 135. Zoetis Pet Anthelmintic Drugs Product
Table 136. Zoetis Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
Table 137. Zoetis Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Anthelmintic Drugs Market Share by Type: 2021 VS 2028
Figure 2. External Features
Figure 3. Internal Features
Figure 4. Composite Features
Figure 5. Injection Features
Figure 6. Global Pet Anthelmintic Drugs Market Share by Application: 2021 VS 2028
Figure 7. Dog Case Studies
Figure 8. Cat Case Studies
Figure 9. Others Case Studies
Figure 10. Pet Anthelmintic Drugs Report Years Considered
Figure 11. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Pet Anthelmintic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pet Anthelmintic Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Pet Anthelmintic Drugs Market Share by Players in 2021
Figure 15. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2021
Figure 17. North America Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Pet Anthelmintic Drugs Market Size Share by Region (2017-2028)
Figure 37. China Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 58. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 59. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 60. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 61. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 62. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 63. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 64. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 65. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 66. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 67. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 68. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 69. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 70. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount